Tech Company Financing Transactions
IDEAYA Biosciences Funding Round
On 5/5/2016, IDEAYA Biosciences landed $46 million in Series A funding from 5AM Ventures, Alexandria Venture Investments and Canaan Partners.
Transaction Overview
Company Name
Announced On
5/5/2016
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series A
Investors
Proceeds Purpose
The company is now capitalized to advance its research programs in synthetic lethality and immuno-oncology to clinical candidate selection and the clinic. IDEAYA was incubated by 5AM Ventures with a seed investment prior to its Series A financing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
7000 Shoreline Ct. 350
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
IDEAYA Biosciences (Nasdaq: IDYA). At the core of a successful big biology and small molecule based drug discovery company is well understood pathobiology of the drug targets and excellent chemical matter to modulate them - one without the other ultimately equals failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yujiro Hata
Chief Medical Officer
Julie Hambleton
Chief Scientific Officer
Michael Dillon
Controller
Andres Briseno
VP - General Counsel
Paul Stone
Browse more venture capital transactions:
Prev: 5/5/2016: Teachable venture capital transaction
Next: 5/5/2016: STAQ venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs